Pfizer has asked the United States government to approve the use of its COVID-19 vaccine for children aged five to 11. The company announced in a tweet on Thursday that it had formally filed its application with the FDA for emergency authorization.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
